Browse By: Country ι Category ι Publisher ι Tag

Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

Pages » 1749
Published By » Current Partnering
Price » $5495
In stock
View Report Details
Description

The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcom...


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995
Orphan Drugs Partnering Terms and Agreements
The Orphan Drugs Partnering Terms and Agreements report provides an understanding and access to the orphan drugs partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in orphan drugs partnering deals Disclosed headlines, upfronts, milestone
Published Date: Aug 2013
Price: $1795
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Sep 2013
Price: $2795
Companion Diagnostics Partnering Terms and Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe companion diagnostics partnering deals and agreements entered intby the worlds leading healthcare companies.   The report provides a detailed underst
Published Date: Oct 2013
Price: $1795
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provide
Published Date: Sep 2013
Price: $2795

 


 

Related News

Egyptian Government to Allow Private Investments in Renewable and New Energy Sector
As Egypt grapples its worst electricity crisis, the country’s government has decided to allow the private sector’s participation in renewable energy initiatives. According to Mohamed Shaker, Egypt’s Minister of Electricity, the government has agreed private sector investments in the production of new and renewable energy in Egypt. However, this participation will be subject to a tariff policy for the government’s purchase of energy produced by the private sector, over the
Date: Aug 28

New App Released By Instagram for Time-lapse Videos
A new iPhone app called Hyperlapse was released by Instagram on Tuesday. This app erases out the disturbances and jitters caused in time-lapse videos. Interestingly, a similar technology was demonstrated by Microsoft a couple of weeks back and that too bearing the same name. According to analysts, this app is a striking feature introduced in the video aspect of smart phones. Passage of time can be depicted by using a widely used video technique called time lapse. However, these effects can be
Date: Aug 28

Germany Trims Non-Renewable Energy Sector, Companies Worry about Growth
Many of Germany’s companies, investors, economists, and neighboring countries are worried about Germany’s move to introduce a large-scale renewable energy program. The country faces enormous costs to replace a system that was already in effect and working, with a project to start utilizing cleaner energy sources. In their effort to gradually wean off nuclear and fossil fuel energy, Germany’s Energiewende plans to spend a trillion Euros to do so. The North Sea wind farm Bard
Date: Aug 27

GM Faulty Ignition-switch Program Registers More than 100 Death Claims
The General Motors’ program built to compensate victims of crashes caused due to faulty ignition switches in company’s vehicles has received 107 claims for death as of Tuesday, according to Amy Weiss, the spokesperson for Kenneth Feinberg - the lawyer handling the program.  Amy stated that the 107 death claims are amongst the 309 claims submitted in the program so far. The program started to accept claims on the 1st August, and will continue till 31st December.  For a
Date: Aug 27

Japan Energy Sector Develops First 250MW Solar Power Project
First Solar Inc., (FSLR)is constructing its first 250 megawatts solar projects in Japan. FSLR is the largest U.S. solar panel maker in the country. Japan witnesses many government incentives that encourage substantial development of solar and cleaner energy sources.  Karl Brutsaert, the director of business development First Solar told that Japan is strategically planning into making investments in utility-scale projects, developing different projects, operating and managing over the lon
Date: Aug 27

BOC Aviation Places Order For Boeing Planes Worth a Record Amount
The leasing subsidiary of Bank of China, BOC Aviation has recently placed the biggest order of planes in its 20-year history. The order, which is reportedly worth $8.8 billion, comprises of two long-haul wide-body planes of the 777-300ER series, 30 Next Generation aircrafts of the 737-800 series, 50 Boeing planes of the 737 Max 8 series. The order comes only a week after the China-based leasing body SMBC Aviation had placed orders for 115 Airbus jet planes.  The huge financing of leasin
Date: Aug 26

Japan to Seek Over ¥5 Trillion Defense Budget
In what is a record-high budget request, the defense ministry of Japan plans to request more than 5 trillion yen in the fiscal year 2015 beginning next April. A formal announcement will be made next Friday and includes high priority costs that are in line with Prime Minister Shinzo Abe’s new strategies on defense and security.  The budget sought after is 3.5% higher than this fiscal year’s request and includes defense of the remote islands of Japan, creation of an amphibious
Date: Aug 25

India to Global Auto Hub by 2020
Global automobile manufacturers are eyeing India as a lucrative option to set up businesses. This shift in perception is due to country’s growing domestic market and its growth potential. The automakers will also focus on exports from India. Report published by Standard Chartered Bank states, for global operations Hyundai will source its engines from India; Ford will manufacture engines in India for its Asia-Pacific and Africa region; and Volkswagen will increase its sourcing from India
Date: Aug 25

New Transparent Material can Work as a Solar Power Generator
A team of scientists at Michigan State University declared this week the creation of a luminescent transparent solar concentrator which has the potential to turn windows and cell phone screens into solar-power generating equipment. This technology can revolutionize the way we use solar power. It cans enable entire skyscrapers one day to generate solar power without obstructing light or the view. This new material works by absorbing light from the invisible spectrum which is ultraviolet and ne
Date: Aug 25

Brits Picks U.S. Companies for Defense Contracts
Bechtel and CH2M Hill, both U.S.-based firms, have been chosen by Britain to operate sections of its military equipment buying program. The British Ministry of Defense (MOD) has made the move in an effort to restructure its equipment purchasing programs for the armed forces, by trying to utilize public spending. This reportedly involves renovating the Defense Equipment & Support (DE&S) segment. The DE&S has been criticized for multiple delays and budget overruns. The MOD plans to
Date: Aug 21

Upcoming Reports

Antiemetic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Antiemetics are therapeutic agents which are used to treat vomiting and nausea caused by several medical conditions. Nausea and vomiting are not diseases, they are symptoms associated with a variety of medical conditions such as gastroenteritis, motion sickness, dizziness, pregnancy, overeating, emo
Published By: Transparency Market Research
Price: $4795
Alzheimers Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down it
Published By: Transparency Market Research
Price: $4795
Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795